Quick Answer
LakeShore Biopharma Co., Ltd. reported Long Term Debt of $23.50 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -76.3% in Long Term Debt from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), LakeShore Biopharma Co., Ltd.'s Long Term Debt has declined by 90.7%.
- Historical annual values: Fiscal year 2025: $23.50 million | Fiscal year 2024: $98.98 million | Fiscal year 2023: $293.79 million | Fiscal year 2022: $253.93 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: